Indoramin-prolongation of repolarization time, a mechanism of bradycardia in man?

British Journal of Clinical Pharmacology
D W HarronR G Shanks

Abstract

The effect of indoramin, a selective alpha 1-adrenoceptor antagonist, on ECG time intervals in normal man was studied. Significant prolongation of QTc was observed after indoramin 100 mg, with no change in QRS duration. In addition, the slope of the RR/QT relationship was changed by indoramin 100 mg. These results suggest that indoramin may have Class III antiarrhythmic activity. If such activity were to affect the SA node, it may explain at least in part the observed lack of reflex tachycardia after indoramin administration.

References

Aug 1, 1978·The Journal of Pharmacy and Pharmacology·K F Rhodes, J F Waterfall
Oct 1, 1978·The Journal of Pharmacy and Pharmacology·D R Algate, J F Waterfall
Sep 1, 1971·The Journal of Pharmacy and Pharmacology·B J AlpsA B Wilson
Jun 1, 1984·British Journal of Clinical Pharmacology·D P NichollsR G Shanks
Jul 1, 1983·British Journal of Pharmacology·J S Millar, E M Vaughan Williams
Dec 1, 1983·British Journal of Clinical Pharmacology·D H Staniforth
Jul 1, 1984·British Journal of Clinical Pharmacology·A W KelmanD J Summer
Jan 1, 1982·Pharmacology & Therapeutics·R S Bexton, A J Camm
Jan 1, 1983·British Journal of Clinical Pharmacology·D P NichollsR G Shanks

Citations

Feb 1, 1987·Journal of the American College of Cardiology·C V LeierD V Unverferth
Apr 1, 1988·British Journal of Clinical Pharmacology·A H DeeringR G Shanks

Related Concepts

Clinical Trials
Electrocardiographic Recorders
Indoles
Wy-21901
Myocardial Contraction
Randomization

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.